DSCM
PRCT icon

Divisadero Street Capital Management’s Procept Biorobotics PRCT Stock Holding History

Divisadero Street Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07M Sell
180,260
-686,078
-79% -$17.2M 0.09% 88
2026
Q1 		$21.7M Buy
+866,338
New +$24.4M 0.91% 31
2025
Q4 		– Sell
-24,963
Closed -$891K – 159
2025
Q3 		$891K Hold
24,963
– – 0.04% 128
2025
Q2 		$1.44M Hold
24,963
– – 0.09% 90
2025
Q1 		$1.45M Buy
+24,963
New +$1.7M 0.15% 63

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Divisadero Street Capital Management's PRCT Position: Q2 2026 in Review

Divisadero Street Capital Management reduced its Procept Biorobotics (PRCT) stake by 79% in Q2 2026, selling an estimated $17.2M and leaving 180,260 shares worth $4.07M. The position accounts for 0.09% of the portfolio, ranked #88.

Divisadero Street Capital Management first reported a position in PRCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $21.7M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Divisadero Street Capital Management held 180,260 shares of Procept Biorobotics worth $4.07M as of Q2 2026.
  • Divisadero Street Capital Management sold 686,078 Procept Biorobotics shares in Q2 2026, an estimated $17.2M.
  • Procept Biorobotics made up 0.09% of Divisadero Street Capital Management's portfolio in Q2 2026, its #88 holding.
  • Divisadero Street Capital Management first reported a position in Procept Biorobotics in Q1 2025 and has held it in 5 quarters since.
  • Divisadero Street Capital Management's Procept Biorobotics position peaked at $21.7M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.